FDA inspection
3D Imaging Drug Design and Development LLC: FDA inspection ending Apr 20, 2017
FDA inspection 1009371 · Official Action Indicated (OAI) · Little Rock, AR
Key facts
| Inspection ID | 1009371 |
|---|---|
| Firm | 3D Imaging Drug Design and Development LLC |
| FEI number | 3009143510 |
| Address | 9015 Carti Way |
| City | Little Rock |
| State | AR |
| ZIP | 72205 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Apr 20, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data